Open the mobile version, with barcode scanning
Class I Ongoing

Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).

Why: Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

Company
Fresenius Kabi USA, LLC
Lake Zurich, IL, United States
Reported
Dec 3, 2025
Recall started
Nov 6, 2025
Where sold
Nationwide within the United States as well as AK, HI, and PR.
Amount
2,199,850 vials
Full product description
Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).
Lots / codes affected
Lot #: 6133156, 6133194, Exp Date: 08/2026; 6133388, Exp Date: 10/2026.

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.